Mutational profiling of bone metastases from lung adenocarcinoma: results of a prospective study (POUMOS-TEC)

Targeted therapies have improved patient survival in metastatic lung adenocarcinoma. Molecular diagnosis is a key element to identify oncogenic drivers predicting the efficacy of these agents. In stage IV patients, histopathological diagnosis is often performed on bone metastases biopsy, but routine...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Confavreux, Cyrille B, Girard, Nicolas, Pialat, Jean-Baptiste, Bringuier, Pierre-Paul, Devouassoux-Shisheboran, Mojgan, Rousseau, Jean-Charles, Isaac, Sylvie, Thivolet-Bejui, Françoise, Clezardin, Philippe, Brevet, Marie
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2014
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181073/
https://ncbi.nlm.nih.gov/pubmed/25328676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bonekey.2014.75
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares